Matthew Plooster

Track

Insider profile

Currently holds a position at Zevra Therapeutics Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Zevra Therapeutics Inc March 1, 2011 -
Matthew Plooster's trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-13 2023-03-09
B Purchase
65,553 -30.9%
473.82
US$236,727 		65,553 -30.9% 473.82 US$236,727
2022-05-18 2022-05-18
B Purchase
71,360 +45.0%
171.98
US$841,495 		71,360 +45.0% 171.98 US$841,495
2022-05-18 2022-05-18
B Purchase
58,018 -29.7%
234.77
US$289,636 		58,018 -29.7% 234.77 US$289,636
2022-05-18 2022-05-18
B Purchase
915 +28.6%
4.95
US$4,529 		915 +28.6% 4.95 US$4,529
2022-05-18 2022-05-18
B Purchase
695 +27.8%
4.94
US$3,433 		695 +27.8% 4.94 US$3,433